Biodesix (BDSX) Current Assets (2019 - 2026)

Biodesix has reported Current Assets for 8 years, with the latest figure at $40.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 38.11% year-over-year to $40.9 million; the trailing twelve-month figure through Mar 2026 stood at $40.9 million (up 38.11% YoY), and the FY2025 full-year result was $32.5 million, down 17.64% from the prior year.
• Current Assets for Q1 2026 stood at $40.9 million, up from $32.5 million in the prior quarter.
• The five-year high for Current Assets was $57.6 million in Q2 2024, with the low at $24.1 million in Q3 2022.
• Historically, Current Assets has averaged $35.7 million across 5 years, with a median of $33.4 million in 2025.
• Annual changes were most pronounced in 2022 — Current Assets tumbled 66.48% — and 2024, when it soared 128.08%.
• Biodesix's Current Assets stood at $53.3 million in 2022, then declined by 25.6% to $39.7 million in 2023, then slipped by 0.5% to $39.5 million in 2024, then declined by 17.64% to $32.5 million in 2025, then climbed by 25.81% to $40.9 million in 2026.
• The last three Current Assets figures came in at $40.9 million (Q1 2026), $32.5 million (Q4 2025), and $33.4 million (Q3 2025), per Business Quant data.